| First Author | Evéquoz D | Year | 2021 |
| Journal | Nucleic Acids Res | Volume | 49 |
| Issue | 21 | Pages | 12089-12105 |
| PubMed ID | 34850138 | Mgi Jnum | J:355039 |
| Mgi Id | MGI:6833658 | Doi | 10.1093/nar/gkab1097 |
| Citation | Evequoz D, et al. (2021) 7',5'-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy. Nucleic Acids Res 49(21):12089-12105 |
| abstractText | Antisense oligonucleotides are small pieces of modified DNA or RNA, which offer therapeutic potential for many diseases. We report on the synthesis of 7',5'-alpha-bc-DNA phosphoramidite building blocks, bearing the A, G, T and MeC nucleobases. Solid-phase synthesis was performed to construct five oligodeoxyribonucleotides containing modified thymidine residues, as well as five fully modified oligonucleotides. Incorporations of the modification inside natural duplexes resulted in strong destabilizing effects. However, fully modified strands formed very stable duplexes with parallel RNA complements. In its own series, 7',5'-alpha-bc-DNA formed duplexes with a surprising high thermal stability. CD spectroscopy and extensive molecular modeling indicated the adoption by the homo-duplex of a ladder-like structure, while hetero-duplexes with DNA or RNA still form helical structure. The biological properties of this new modification were investigated in animal models for Duchenne muscular dystrophy and spinal muscular atrophy, where exon splicing modulation can restore production of functional proteins. It was found that the 7',5'-alpha-bc-DNA scaffold confers a high biostability and a good exon splicing modulation activity in vitro and in vivo. |
